Whereas biotechs and other medicals near buy points have dominated the Your Weekly Review list, this week’s stocks are a mixed bag. These four stocks share two common traits: They’re leaders in their groups, and they’re in buy range. Keep in mind that all buys are riskier with earnings season and the market uptrend under pressure.